The full bill
Ask for a total you can compare.
Some online weight-care services charge a membership fee each month, with medicine paid for separately. This price structure was checked September 26, 2026.
One service’s fee does not tell you another service’s total.
Ask for separate amounts for the first visit, later visits, membership, medicine, lab work, and delivery.
Ask which charges continue if treatment does not begin, and how a membership ends.
An example of a medicine-only price
Read “starting at” closely.
Self-pay means paying outside insurance.
The government’s price page for semaglutide (Wegovy) tablets listed a cash offer starting at $149 per month on September 26, 2026.
The $149 price was for the tablet with the smallest amount of medicine. Tablets with more medicine cost $199 or $299 per month.
Ask which tablet your prescription names and what that exact tablet costs. Ask about the price when you need more medicine.
Ask for the online visit and lab work to be priced separately.
Insurance approval
Check the plan’s answer before relying on it.
A medicine may be eligible for Medicare coverage, yet your plan may still decline to pay. This was checked September 26, 2026.
Ask if the medicine is on your plan’s list and if the plan must approve it before paying. That approval step is called prior authorization.
Ask the insurer about the exact product, the reason it is prescribed, and any approval steps.
Ask who sends the paperwork and what happens if the plan declines.
Medicare
The reason for the prescription matters.
Medicare’s usual medicine coverage is called Part D. It leaves out medicines used to help people lose weight. This rule was checked September 26, 2026.
A medicine used to treat type 2 diabetes or reduce certain heart risks may qualify for Part D coverage. The exact product and your plan’s rules still matter.
Ask which rule applies to the health problem your prescription is meant to treat.
A temporary Medicare programme
Check whether the Bridge is open to you.
The term GLP-1 refers to a group of medicines for diabetes and weight care.
The temporary Medicare programme called the GLP-1 Bridge sits outside usual Part D coverage. As of September 26, 2026, people accepted into it pay $50 per month for a covered weight medicine.
That payment is called a copay: the patient pays that part of the bill while the programme pays the rest.
It covers orforglipron (Foundayo) tablets, semaglutide (Wegovy) tablets or injections, and tirzepatide (Zepbound) in a pen device called a KwikPen.
Zepbound’s single-use pens and small bottles are excluded.
The programme’s first day is July 1, 2026; its last is December 31, 2027. Eligibility depends on health and plan rules.
Applicants must be at least 18 and in an eligible Medicare drug plan. Weight requirements differ for people with heart, blood pressure, kidney, or other listed health problems.
People who have type 2 diabetes go through ordinary Part D instead. The Bridge cannot cover you in 2026 if Part D already covered a GLP-1 medicine for you that year.
Other health and plan exclusions apply. Ask whoever writes your prescription to go through the full linked criteria with you.
A prescription and prior approval are required.
Read Medicare’s programme termsCash offers
Check eligibility and the end date.
The medicine’s maker may offer a savings card to reduce what you pay through private or workplace insurance.
For these brand medicines, the savings cards exclude people on Medicare, Medicaid, or military health plans. This was checked September 26, 2026.
A separate cash offer from the medicine’s maker may still be available if you have Medicare or another government plan. You pay outside insurance and do not use the savings card.
Many introductory prices and savings-card terms have a December 31, 2026 end date.
Check the offer again after its end date. The printed terms do not promise what the next price will be.